Details for Patent: 9,868,745
✉ Email this page to a colleague
Title: | Antiviral compounds |
Abstract: | The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. |
Inventor(s): | Bacon; Elizabeth M. (Burlingame, CA), Cottell; Jeromy J. (Redwood City, CA), Katana; Ashley Anne (San Mateo, CA), Kato; Darryl (San Francisco, CA), Krygowski; Evan S. (Washington, DC), Link; John O. (San Francisco, CA), Taylor; James G. (San Mateo, CA), Tran; Chinh Viet (San Diego, CA), Trejo Martin; Teresa Alejandra (Union City, CA), Yang; Zheng-Yu (Palo Alto, CA), Zipfel; Sheila (San Mateo, CA) |
Assignee: | Gilead Pharmasset LLC (Foster City, CA) |
Filing Date: | Nov 13, 2014 |
Application Number: | 14/541,057 |
Claims: | 1. A composition comprising: (1) a compound of formula: ##STR00183## (2) a NS5B polymerase inhibitor; and (3) a NS3 protease inhibitor. 2. The composition of claim 1, wherein the NS3 protease inhibitor is boceprevir. 3. The composition of claim 1, wherein the NS3 protease inhibitor is telaprevir. 4. The composition of claim 1, wherein the NS3 protease inhibitor is TMC435350. 5. The composition of claim 1, wherein the NS3 protease inhibitor is BI-1335. 6. The composition of claim 1, wherein the NS3 protease inhibitor is BI-1230. 7. The composition of claim 1, wherein the NS3 protease inhibitor is MK-7009. 8. The composition of claim 1, wherein the NS3 protease inhibitor is VBY-376. 9. The composition of claim 1, wherein the NS3 protease inhibitor is ITMN-191. |